Research Papers

19 of 969 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Interleukin-1 exerts distinct actions on different cell types of the brain in vitro.
An Y; Chen Q; Quan N.
J Inflamm Res (Unknown)
Published: 2011
1/6 Transparent
Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular sig…
Das UN.
J Inflamm Res (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
Current and emerging strategies for the treatment of acute pericarditis: a systematic review.
Sheth S; Wang DD; Kasapis C.
J Inflamm Res (Unknown)
Published: 2010
1/6 Transparent
Deletion of PPAR-γ in immune cells enhances susceptibility to antiglomerular basement membrane disease.
Chafin C; Muse S; Hontecillas R; Bassaganya-Riera J; Caudell DL; Shimp SK; Rylander MN; Zhang J; Li L; Reilly CM.
J Inflamm Res (Unknown)
Published: 2010
1/6 Transparent
The effect of smoking on the symptoms and progression of multiple sclerosis: a review.
Shirani A; Tremlett H.
J Inflamm Res (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
Potential of anti-inflammatory treatment for cystic fibrosis lung disease.
Taylor-Cousar JL; Von Kessel KA; Young R; Nichols DP.
J Inflamm Res (Unknown)
Published: 2010
1/6 Transparent
Current perspectives on the role of IL-17 in autoimmune disease.
Yamada H.
J Inflamm Res (Unknown)
Published: 2010
1/6 Transparent
Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis.
Jankovic SM.
J Inflamm Res (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
Topical alpha-selective p38 MAP kinase inhibition reduces acute skin inflammation in guinea pig.
Medicherla S; Ma JY; Reddy M; Esikova I; Kerr I; Movius F; Higgins LS; Protter AA.
J Inflamm Res (Unknown)
Published: 2010
1/6 Transparent
Rilonacept in the management of cryopyrin-associated periodic syndromes (CAPS).
Gillespie J; Mathews R; McDermott MF.
J Inflamm Res (Unknown)
Published: 2010
1/6 Transparent
Correlation of measurable serum markers of inflammation with lung levels following bilateral femur fracture in a rat mo…
Sears BW; Volkmer D; Yong S; Himes RD; Lauing K; Morgan M; Stover MD; Callaci JJ.
J Inflamm Res (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
Existence of seven human IL-1R1 promoters.
Li Q; Zhang H; Chen Q; Quan N.
J Inflamm Res (Unknown)
Published: 2010
1/6 Transparent
Etiology and treatment of the inflammatory causes of cystoid macular edema.
Cho H; Madu A.
J Inflamm Res (Unknown)
Published: 2009
1/6 Transparent
Etanercept, improved dosage schedules and combinations in the treatment of psoriasis: an update.
Segaert S.
J Inflamm Res (Unknown)
Published: 2009
1/6 Transparent
Inflammatory mediators: Parallels between cancer biology and stem cell therapy.
Patel SA; Heinrich AC; Reddy BY; Rameshwar P.
J Inflamm Res (Unknown)
Published: 2009
2/6 Transparent
Funding Declared
Inflammatory mechanisms in the lung.
Moldoveanu B; Otmishi P; Jani P; Walker J; Sarmiento X; Guardiola J; Saad M; Yu J.
J Inflamm Res (Unknown)
Published: 2008
1/6 Transparent
Funding Declared
Local anesthetic failure associated with inflammation: verification of the acidosis mechanism and the hypothetic partic…
Ueno T; Tsuchiya H; Mizogami M; Takakura K.
J Inflamm Res (Unknown)
Published: 2008
2/6 Transparent
Funding Declared
Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer's disease.
McAlpine FE; Tansey MG.
J Inflamm Res (Unknown)
Published: 2008
1/6 Transparent
Role of toll-like receptor 4 in acute neutrophilic lung inflammation induced by intratracheal bacterial products in mic…
Yamada W; Tasaka S; Koh H; Shimizu M; Ogawa Y; Hasegawa N; Miyasho T; Yamaguchi K; Ishizaka A.
J Inflamm Res (Unknown)
Published: 2008
2/6 Transparent
Funding Declared